Oral N-acetylcysteine and exacerbation rates in patients with chronic bronchitis and severe airways obstruction. British Thoracic Society Research Committee.-Reference-Cited by-同舟云学术

Oral N-acetylcysteine and exacerbation rates in patients with chronic bronchitis and severe airways obstruction. British Thoracic Society Research Committee.

Published:1985-11-01 Issue:11 Volume:40 Page:832-835
ISSN:0040-6376
Container-title:Thorax
language:en
Short-container-title:Thorax

Author:

Publisher

BMJ

Subject

Pulmonary and Respiratory Medicine

Reference4 articles.

1. Oral acetylcysteine reduces exacerbation rate in chronic bronchitis: report of a trial organised by the Swedish Society for Pulmonary Diseases;Boman, G.; Backer, U.; Larsson, S.;EurJ Resp Dis,1983

2. Long term oral acetylcysteine in chronic bronchitis. A double blind controlled study;Group, Multicentre Study;Eur J Respir Dis

3. Theoretical statistics;Cox, D.R.; Hinkley, D.V.,1974

4. Analysis of binary data;Cox, DR,1977

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. N-acetylcysteine Treatment in Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis/Pre-COPD: Distinct Meta-analyses;Archivos de Bronconeumología;2024-05

2. Recent Advances in the Development of Novel Drug Candidates for Regulating the Secretion of Pulmonary Mucus;Biomolecules & Therapeutics;2020-07-01

3. Effect of Orally Administered N-Acetylcysteine on Chronic Bronchitis: A Meta-analysis;Advances in Therapy;2019-10-09

4. Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease;Cochrane Database of Systematic Reviews;2019-05-20

5. Cysteine/Glutathione Deficiency: A Significant and Treatable Corollary of Disease;The Therapeutic Use of N-Acetylcysteine (NAC) in Medicine;2018-09-21